The positive opinion is based on the landmark EMPEROR-Preserved Phase III trial, which showed significant outcomes in patients with heart failure with left ventricular ejection fraction over 40%1 If approved,… Read More
Health Canada list identifies select companies that can supply psilocybin to approved applicants through the Special Access Program for patient treatment VANCOUVER, B.C. – Numinus Wellness Inc. (“Numinus” or the… Read More
If your organization is looking for talented grad students for positions starting in January, May or September 2022, please consider the MedTech Talent Accelerator. The accelerator is a training program designed to… Read More
Interim data submitted to the FDA show majority of pre-symptomatic babies treated with Evrysdi for at least one year were able to sit, stand and walk within timeframes typical of healthy babies,… Read More
New Drug Application submission planned for second quarter of 2022 Full data set to be presented at an upcoming medical meeting SAN MATEO, C.A. – Sierra Oncology, Inc. (NASDAQ: SRRA),… Read More
